1.01
price up icon0.50%   0.005
after-market 시간 외 거래: 1.02 0.01 +0.99%
loading

Adial Pharmaceuticals Inc 주식(ADIL)의 최신 뉴스

pulisher
09:42 AM

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer - citybiz

09:42 AM
pulisher
Oct 23, 2024

Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference - The Manila Times

Oct 23, 2024
pulisher
Oct 17, 2024

EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate - AOL

Oct 17, 2024
pulisher
Oct 17, 2024

Adial Pharmaceuticals patent expands for alcohol disorder drug - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

Adial Pharmaceuticals patent expands for alcohol disorder drug By Investing.com - Investing.com Canada

Oct 17, 2024
pulisher
Oct 17, 2024

Adial Pharmaceuticals Receives Notice of Allowance for U.S. - GlobeNewswire

Oct 17, 2024
pulisher
Oct 15, 2024

Adial Pharmaceuticals Commends the National Institute on Alcohol Abuse and Alcoholism's New Definition of Recovery - GlobeNewswire

Oct 15, 2024
pulisher
Sep 26, 2024

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Down 46.2% in September - Defense World

Sep 26, 2024
pulisher
Sep 19, 2024

Analyzing ADI’s price-to-book ratio for the last quarter - US Post News

Sep 19, 2024
pulisher
Sep 19, 2024

Adial Pharmaceuticals completes key study stage for AUD drug - Investing.com

Sep 19, 2024
pulisher
Sep 19, 2024

Adial Pharmaceuticals Announces Database Lock in - GlobeNewswire

Sep 19, 2024
pulisher
Sep 19, 2024

Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder - StockTitan

Sep 19, 2024
pulisher
Sep 19, 2024

Analog Devices Inc. (ADI) Stock: A Year of Declines and Increases - The InvestChronicle

Sep 19, 2024
pulisher
Sep 19, 2024

MQS Management LLC Increases Stock Position in Analog Devices, Inc. (NASDAQ:ADI) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Addex Therapeutics Reports Profitable H1 2024 - TipRanks

Sep 19, 2024
pulisher
Sep 19, 2024

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit - GlobeNewswire

Sep 19, 2024
pulisher
Sep 18, 2024

Recent Insider Activity Could Benefit Adaptimmune Therapeutics Plc ADR (ADAP) - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

ADMA Biologics stock soars to all-time high of $19.36 - Investing.com

Sep 18, 2024
pulisher
Sep 18, 2024

ADMA Biologics Stock Soars 76.2% in 3 Months: Right Time to Invest? - Yahoo Finance

Sep 18, 2024
pulisher
Sep 18, 2024

Adial Pharmaceuticals (NASDAQ:ADIL) versus Galapagos (NASDAQ:GLPG) Head-To-Head Comparison - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Analog Devices (NASDAQ:ADI) shareholders notch a 17% CAGR over 5 years, yet earnings have been shrinking - Yahoo Finance

Sep 18, 2024
pulisher
Sep 18, 2024

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Eagle-Tribune

Sep 18, 2024
pulisher
Sep 18, 2024

ADM Investor Services Singapore Becomes Abaxx Exchange's Third Clearing and Trading Member - GlobeNewswire

Sep 18, 2024
pulisher
Sep 18, 2024

Raymond James lifts Adma Biologics Inc [ADMA] price estimate. Who else is bullish? - The DBT News

Sep 18, 2024
pulisher
Sep 17, 2024

Keeping an Eye on Adma Biologics Inc (ADMA) After Insider Trading Activity - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

Adma Biologics Inc (NASDAQ:ADMA) stock crossing the finish line today - US Post News

Sep 17, 2024
pulisher
Sep 17, 2024

Analytical Overview: Adma Biologics Inc (ADMA)’s Ratios Tell a Financial Story - The Dwinnex

Sep 17, 2024
pulisher
Sep 17, 2024

A new trading data show Adaptimmune Therapeutics Plc ADR (ADAP) is showing positive returns. - SETE News

Sep 17, 2024
pulisher
Sep 17, 2024

ADIA Nutrition Stakes Claim in $6.7B Industry with Strategic Trademark Expansion - Marketscreener.com

Sep 17, 2024
pulisher
Sep 17, 2024

ADMA Biologics set to join S&P SmallCap 600 index By Investing.com - Investing.com Canada

Sep 17, 2024
pulisher
Sep 17, 2024

Take off with Applied Dna Sciences Inc (APDN): Get ready for trading - SETE News

Sep 17, 2024
pulisher
Sep 17, 2024

ADMA Biologics Set to Join S&P SmallCap 600 Index - Yahoo Finance

Sep 17, 2024
pulisher
Sep 16, 2024

Adma Biologics Inc (ADMA) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

Sep 16, 2024
pulisher
Sep 16, 2024

Adma Biologics Inc (ADMA) Performance and Fundamentals Dashboard tells a completely different story - SETE News

Sep 16, 2024
pulisher
Sep 16, 2024

Predicting Adaptimmune Therapeutics Plc ADR’s (ADAP) earnings for the current quarter - US Post News

Sep 16, 2024
pulisher
Sep 16, 2024

Balance Sheet Insights: Applied Dna Sciences Inc (APDN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Sep 16, 2024
pulisher
Sep 16, 2024

The Attractiveness of Investing In Analog Devices Inc. (ADI) is Growing - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

Applied Dna Sciences Inc (APDN) is a good investment, but the stock may be undervalued - US Post News

Sep 16, 2024
pulisher
Sep 16, 2024

Applied Dna Sciences Inc: Navigating Market Fluctuations with a 14.11M Market Cap - The InvestChronicle

Sep 16, 2024
pulisher
Sep 16, 2024

Small-cap stars are buying this forecast-smashing biotech - Citywire New Model Adviser

Sep 16, 2024
pulisher
Sep 16, 2024

Q2 2026 EPS Estimates for Analog Devices, Inc. Decreased by Analyst (NASDAQ:ADI) - MarketBeat

Sep 16, 2024
pulisher
Sep 16, 2024

Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Declines By 14.5% - Defense World

Sep 16, 2024
pulisher
Sep 15, 2024

Analog Devices (NASDAQ:ADI) shareholders notch a 16% CAGR over 5 years, yet earnings have been shrinking - Simply Wall St

Sep 15, 2024
pulisher
Sep 13, 2024

ADMA Shares Experience Surge in Value - Knox Daily

Sep 13, 2024
pulisher
Sep 13, 2024

Analog Devices Inc. (ADI) did well last session? - US Post News

Sep 13, 2024
pulisher
Sep 04, 2024

Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Sep 04, 2024
pulisher
Sep 02, 2024

Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Increases By 8.3% - Defense World

Sep 02, 2024
pulisher
Aug 31, 2024

Reviewing Adial Pharmaceuticals (NASDAQ:ADIL) and Ultragenyx Pharmaceutical (NASDAQ:RARE) - Defense World

Aug 31, 2024
pulisher
Aug 21, 2024

EXCLUSIVE: Adial Pharmaceuticals Advances Regulatory Strategy For Companion Diagnostic Genetic Test For Its Lead Program For Alcohol Use Disorder - MSN

Aug 21, 2024
pulisher
Aug 17, 2024

Brookline Capital Management Research Analysts Cut Earnings Estimates for Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) - Defense World

Aug 17, 2024
pulisher
Aug 16, 2024

Thinking about buying stock in Rivian Automotive, Joby Aviation, - GuruFocus.com

Aug 16, 2024
pulisher
Aug 14, 2024

Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Aug 14, 2024
pulisher
Aug 14, 2024

ADILAdial Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Aug 14, 2024
pulisher
Aug 13, 2024

ADIL Stock Earnings: Adial Pharmaceuticals Reported Results for Q2 2024 - InvestorPlace

Aug 13, 2024
pulisher
Aug 13, 2024

Adial Pharmaceuticals partners with Boudicca Dx for FDA strategy - Investing.com

Aug 13, 2024
pulisher
Aug 13, 2024

Adial Pharmaceuticals partners with Boudicca Dx for FDA strategy By Investing.com - Investing.com South Africa

Aug 13, 2024
pulisher
Aug 13, 2024

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Up 92.5% in July - Defense World

Aug 13, 2024
pulisher
Aug 13, 2024

Adial Pharmaceuticals Signs Agreement with Boudicca Dx to - GlobeNewswire

Aug 13, 2024
pulisher
Aug 13, 2024

Adial Pharmaceuticals Signs Agreement with Boudicca Dx to Advance Regulatory Strategy for Companion Diagnostic Genetic Test for AD04 - StockTitan

Aug 13, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):